AI optimism hits a reality check as Microsoft posts its worst quarter since 2008, raising doubts about near-term returns from massive AI investments. Competition from Google, OpenAI and Anthropic intensifies as Copilot adoption lags expectations. Meanwhile, McCormick’s $45B acquisition of Unilever’s food unit signals a major shift in consumer staples strategy. Wall Street rallies hard, with the Dow surging over 1,100 points, as investors weigh geopolitics, oil and positioning. In corporate moves, Nvidia backs Marvell Technology, while Eli Lilly expands into sleep therapeutics. Closer to home, STI weakness masks deeper corrections in names like City Developments Limited and Jardine Matheson - hosted by Michelle Martin with Ryan Huang. See omnystudio.com/listener for privacy information.

AI optimism hits a reality check as Microsoft posts its worst quarter since 2008, raising doubts about near-term returns from massive AI investments. Competition from Google, OpenAI and Anthropic intensifies as Copilot adoption lags expectations. Meanwhile, McCormick&rsquo;s $45B acquisition of Unilever&rsquo;s food unit signals a major shift in consumer staples strategy. Wall Street rallies hard, with the Dow surging over 1,100 points, as investors weigh geopolitics, oil and positioning. In corporate moves, Nvidia backs Marvell Technology, while Eli Lilly expands into sleep therapeutics. Closer to home, STI weakness masks deeper corrections in names like City Developments Limited and Jardine Matheson - hosted by Michelle Martin with Ryan Huang.&nbsp;See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Market View: Wall Street moving higher, AI hype meets reality & Eli Lilly eyes expansion beyond GLP-1